Publications by authors named "Emre Dal"

Claim this Profile
R
Real-world Effectiveness of Single-Agent Enfortumab Vedotin in Patients With Advanced Urothelial Carcinoma.
Nicolas Sayegh, Yeonjung Jo, Georges Gebrael, Nishita Tripathi, Beverly Chigarira, Emre Dal

Clin Genitourin Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Tumor Gene Expression Profiles Between De Novo Metastatic Castration-sensitive Prostate Cancer and Metastatic Relapse After Prior Localized Therapy.
Vinay Mathew Thomas, Nicolas Sayegh, Beverly Chigarira, Georges Gebrael, Nishita Tripathi, Emre Dal

Eur Urol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy with relugolix.
Patrick Campbell, Georges Gebrael, Arshit Narang, Chadi Hage Chehade, Vinay Mathew Thomas, Emre Dal

Ther Adv Urol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor.
Georges Gebrael, Yeonjung Jo, Vinay Mathew Thomas, Haoran Li, Nicolas Sayegh, Emre Dal

Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of ChatGPT 4.0 in Telemedicine-Based Management of Metastatic Prostate Carcinoma.
Emre Dal, Ayana Srivastava, Beverly Chigarira, Chadi Hage Chehade, Vinay Matthew Thomas

Diagnostics (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting.
Georges Gebrael, Chadi Hage Chehade, Nicolas Sayegh, Nishita Tripathi, Beverly Chigarira, Emre Dal

Prostate· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI.
Vinay Mathew Thomas, Beverly Chigarira, Georges Gebrael, Nicolas Sayegh, Nishita Tripathi, Emre Dal

JCO Precis Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmembrane protein 176B regulates amino acid metabolism through the PI3K-Akt-mTOR signaling pathway and promotes gastric cancer progression.
Jing Li, ZiQing Fang, Emre Dal, Hao Zhang, KeXun Yu

Cancer Cell Int· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of response to neoadjuvant therapy in urothelial cancer.
Nishita Tripathi, Gliceida Galarza Fortuna, Georges Gebrael, Emre Dal, Vinay Mathew Thomas

Crit Rev Oncol Hematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tousled-like kinase 1 promotes gastric cancer progression by regulating the tumor growth factor-beta signaling pathway.
Ruo-Chuan Sun, Jing Li, Ya-Xian Li, Hui-Zhen Wang, Emre Dal

World J Gastroenterol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment.
Yufeng Wang, David L Drum, Ruochuan Sun, Yida Zhang, Feng Chen, Emre Dal

Nat Commun· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs.
Ran Qi, Yixuan Bai, Kun Li, Nanbin Liu, Yan Xu, Emre Dal

Drug Resist Updat· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis